These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 39062515)

  • 1. Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas.
    Papadimitrakis D; Perdikakis M; Gargalionis AN; Papavassiliou AG
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
    Baraniskin A; Kuhnhenn J; Schlegel U; Maghnouj A; Zöllner H; Schmiegel W; Hahn S; Schroers R
    Neuro Oncol; 2012 Jan; 14(1):29-33. PubMed ID: 21937590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
    Fujioka Y; Hata N; Akagi Y; Kuga D; Hatae R; Sangatsuda Y; Michiwaki Y; Amemiya T; Takigawa K; Funakoshi Y; Sako A; Iwaki T; Iihara K; Mizoguchi M
    J Neurooncol; 2021 Mar; 152(1):47-54. PubMed ID: 33417137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
    Kopkova A; Sana J; Fadrus P; Slaby O
    Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating glioma biomarkers.
    Kros JM; Mustafa DM; Dekker LJ; Sillevis Smitt PA; Luider TM; Zheng PP
    Neuro Oncol; 2015 Mar; 17(3):343-60. PubMed ID: 25253418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
    Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
    Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
    Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
    Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Advances and Future Perspectives of Cerebrospinal Fluid Biopsy in Midline Brain Malignancies.
    Pan Y; Long W; Liu Q
    Curr Treat Options Oncol; 2019 Nov; 20(12):88. PubMed ID: 31784837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?
    Simonelli M; Dipasquale A; Orzan F; Lorenzi E; Persico P; Navarria P; Pessina F; Nibali MC; Bello L; Santoro A; Boccaccio C
    Crit Rev Oncol Hematol; 2020 Feb; 146():102879. PubMed ID: 32005411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.
    Qu K; Lin T; Pang Q; Liu T; Wang Z; Tai M; Meng F; Zhang J; Wan Y; Mao P; Dong X; Liu C; Niu W; Dong S
    Oncotarget; 2016 Jun; 7(23):33994-4010. PubMed ID: 27166186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Cancer Sci; 2018 Sep; 109(9):2651-2659. PubMed ID: 29949235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas.
    Möhn N; Hounchonou HF; Nay S; Schwenkenbecher P; Grote-Levi L; Al-Tarawni F; Esmaeilzadeh M; Schuchardt S; Schwabe K; Hildebrandt H; Thiesler H; Feuerhake F; Hartmann C; Skripuletz T; Krauss JK
    J Neurol; 2024 Oct; 271(10):6970-6982. PubMed ID: 39227460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA biomarkers for glioma and predicting response to therapy.
    Tumilson CA; Lea RW; Alder JE; Shaw L
    Mol Neurobiol; 2014 Oct; 50(2):545-58. PubMed ID: 24696266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers.
    Díaz Méndez AB; Tremante E; Regazzo G; Brandner S; Rizzo MG
    Neuropathol Appl Neurobiol; 2021 Jun; 47(4):471-487. PubMed ID: 33403678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsies in patients with diffuse glioma.
    Best MG; Sol N; Zijl S; Reijneveld JC; Wesseling P; Wurdinger T
    Acta Neuropathol; 2015 Jun; 129(6):849-65. PubMed ID: 25720744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA.
    Azad TD; Jin MC; Bernhardt LJ; Bettegowda C
    Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Circulating Biomarkers of Brain Tumors.
    Jelski W; Mroczko B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.